NEVO DORON 4
4 · BIOCANCELL THERAPEUTICS INC. · Filed Jan 5, 2010
Insider Transaction Report
Form 4
BIOCANCELL THERAPEUTICS INC.BICL.TA
NEVO DORON
Director
Transactions
- Award
Option to Purchase Common Stock
2009-12-31+20,000→ 20,000 totalExp: 2019-12-31→ Common Stock, par value $0.01 (20,000 underlying)
Footnotes (3)
- [F1]The exercise price is 3.17 NIS per share.
- [F2]10,000 options shall vest and be exercisable on each of June 30, 2010 and December 31, 2010.
- [F3]The Reporting Person holds an additional 40,000 options to purchase Common Stock, at an exercise price of $0.597 each.